SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-24-024533
Filing Date
2024-02-15
Accepted
2024-02-15 16:15:21
Documents
5
Effectiveness Date
2024-02-15

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm246116d1_s8pos.htm S-8 POS 44829
2 EXHIBIT 4.5 tm246116d1_ex4-5.htm EX-4.5 287634
3 EXHIBIT 4.6 tm246116d1_ex4-6.htm EX-4.6 196652
4 EXHIBIT 4.7 tm246116d1_ex4-7.htm EX-4.7 186015
5 GRAPHIC tm246116d1_ex4-7img001.jpg GRAPHIC 2931
  Complete submission text file 0001104659-24-024533.txt   720334
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-250207 | Film No.: 24643987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)